(2R,3S,4S,5R,6R)-3,4-Dihydroxy-6-[(2R,3R,4R,5R)-6-hydroxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-5-sulfooxyoxane-2-carboxylic acid

Term ID

CHEBI:154027

Synonyms

2-O-sulfo-alpha-L-ido-hexopyranosyluronic acid-(1->4)-2-deoxy-3-O-sulfo-2-sulfoamino-D-gluco-hexopyranose
IdoA2S(a1-4)GlcNS3S
WURCS=2.0/2,2,1/[a2122h-1x_1-5_2*NSO/3=O/3=O_3*OSO/3=O/3=O][a2121A-1a_1-5_2*OSO/3=O/3=O]/1-2/a4-b1

Definition

References

GlyGen:G78472VV
GlyTouCan:G78472VV

Ontology

ChEBI ( EBI )

Relationships

is a type of: glucosiduronic acid

glucosiduronic acid Show first 5 Terms

Phenotype

Phenotype resulting from (2R,3S,4S,5R,6R)-3,4-Dihydroxy-6-[(2R,3R,4R,5R)-6-hydroxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-5-sulfooxyoxane-2-carboxylic acid

Phenotype where environments contain (2R,3S,4S,5R,6R)-3,4-Dihydroxy-6-[(2R,3R,4R,5R)-6-hydroxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-5-sulfooxyoxane-2-carboxylic acid

Phenotype modified by environments containing (2R,3S,4S,5R,6R)-3,4-Dihydroxy-6-[(2R,3R,4R,5R)-6-hydroxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-5-sulfooxyoxane-2-carboxylic acid

Human Disease Model